Tovaxin

· Opexa Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Tovaxin, covering 2016-03-15 to 2017-01-11. Get the full timeline:

Most recent: Clinical Trial Update: Dose-Escalation Study of T Cell Vaccine in Multiple Sclerosis [Phase 1, Phase 2]